Research on ENT cancers

Institut Curie focuses its research on ENT cancers around several areas aimed at developing new treatments:

• Therapeutic vaccine: sometimes personalized for each patient depending on their specific tumor, it would induce an immune response preventing relapse after treatment (like preventive vaccines, which would prevent the development of cancer)
• Nanoparticles: metallic nanoparticles are injected directly into the tumor to make radiotherapy more effective by destroying tumor cells without affecting the surrounding healthy tissues.
• Bispecific antibodies (molecules capable of binding to both tumor cells and cells of the immune system in order to facilitate the destruction of cancer cells by the immune system) or conjugated antibodies (which transport chemotherapy "bubbles" to deliver them directly to the tumor).
• The search for biomarkers to predict the patients' response to different treatments.
• New therapeutic targets for immunotherapies.